Patients with cancer and tachycardia had an increased risk for mortality near the time of treatment, according to results presented at the American College of Cardiology’s Advancing the Cardiovascular ...

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Untreated or unmanaged, SVT can lead to other possibly fatal heart abnormalities. Patients are advised to practice a cardiac-friendly diet and lifestyle (low sodium, little to no caffeine or alcohol, ...

We reviewed randomized controlled trials, review articles and clinical practice guidelines to present a practical approach to the diagnosis and management of SVTs (Box 1). We focus on the most common ...

Ventricular tachycardia (VT) after palliative repair of congenital heart disease is relatively rare. Despite this rarity, VT is a known cause of early, intermediate and late morbidity and mortality in ...

A recent study published in Pacing and Clinical Electrophysiology (PACE) determined that the use of catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients. This ...

EXETER, UK — Patients with supraventricular tachycardia (SVT) treated with a modified Valsalva maneuver are nearly four times more likely to return to normal sinus rhythm than individuals treated with ...

A simple, safe and cost-free modification to a physical technique used to treat patients in the emergency department with an abnormally fast heart rhythm could improve its effectiveness by more than a ...

Splanchnic venous thrombosis served as an indicator for occult cancer, according to study results. Further, these blood clots were prognostic for poorer survival outcomes in patients with liver and ...